ProUroCare Medical Inc.
ProUroCare Medical Inc.
Your view on PUMD
Overview
What the company does, where it operates, and who runs it.
About ProUroCare Medical Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Benjamin Banks
- Headquarters
- 6440 Flying Cloud Drive, Eden Prairie, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Benjamin Banks
- Headquarters
- 6440 Flying Cloud Drive, Eden Prairie, US
ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam.
The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for ProUroCare Medical Inc., and the rating behind it. PUMD last traded at $0.0002; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for ProUroCare Medical Inc.. Starting points for ProUroCare Medical Inc.: EPS -$0.17, beta -0.62 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for ProUroCare Medical Inc.. ProUroCare Medical Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for ProUroCare Medical Inc.. Trailing twelve-month EPS for ProUroCare Medical Inc. stands at -$0.17. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for ProUroCare Medical Inc.. ProUroCare Medical Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
ProUroCare Medical Inc. valued side by side against its closest peers. ProUroCare Medical Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold ProUroCare Medical Inc., and how their positions are changing. At a $3,721 market value, institutional positions materially move ProUroCare Medical Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by ProUroCare Medical Inc. executives and directors. Shares of ProUroCare Medical Inc. have traded between $0.0001 and $0.0002 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming ProUroCare Medical Inc.. ProUroCare Medical Inc. is a $3,721 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming ProUroCare Medical Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for ProUroCare Medical Inc.. Coverage tracks ProUroCare Medical Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.